Table 1. Metric comparison between robotic and laparoscopic donor nephrectomy approaches.

The immune checkpoint inhibitor combination regimen has become the initial standard of care for metastatic RCC, given its ...

The 2025 South Central AUA annual meeting included a session on bladder cancer, featuring a presentation from Dr. Yair Lotan ...

In a real-world, multi-center cohort, patients receiving LHRH agonists as compared to LHRH antagonists were found to be at ...

Moderated by Dr. Thomas Chi (UAB), the panel featured Dr. Vernon Pais (Dartmouth), Dr. Karen Stern (Mayo Clinic Arizona), Dr.

WCET 2025: Suction Technology Utility in Mini-PCNL Study: Results of a Real World Multicenter Registry on Behalf of the Endourology Section of the European Association of Urology and the Suction Mini ...

In the past 20 years, minimally invasive surgery has become the standard, Dr. Zhang began. Robotics now propels us into a new age of development, with three-dimensional vision and complete freedom of ...

Neoadjuvant systemic therapy was acceptable to 70% of patients, with 69% of those willing to undergo renal mass biopsy first. While 52% would consider neoadjuvant systemic therapy for ≥16 weeks and 56 ...

Detalimogene voraplasmid is a novel, investigational, non-integrating, non-viral genetic medicine-based immunotherapy carrying a plasmid that simultaneously expresses IL-12 and regulators of RIG-I.

Dr. Palacios concluded his presentation discussing the role of an intraoperative steep Trendelenburg break during robot-assisted laparoscopic radical prostatectomies with the following take-home ...

These results suggest that anti-CTLA4 ICI synergizes with the Ad-PS2 vaccine to generate a robust cytotoxic T-cell response capable of inducing both primary tumor clearance and long-term resistance, ...

Dr. Valdes concluded this presentation discussing whether artificial intelligence can match multidisciplinary expertise in managing high and very high risk prostate cancer with positive surgical ...